-
1.NEW IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS 失效
标题翻译: 新的咪唑啉酮和咪唑啉酮衍生物作为11B-HSD1抑制剂公开(公告)号:US20080103183A1
公开(公告)日:2008-05-01
申请号:US11871318
申请日:2007-10-12
申请人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart , Tadakatsu Takahashi
发明人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart , Tadakatsu Takahashi
IPC分类号: A61K31/4166 , A61K31/4439 , A61P3/00 , C07D233/70 , C07D401/04
CPC分类号: C07D233/02 , A61K9/2054 , A61K9/4866 , C07D233/06 , C07D233/10 , C07D233/28 , C07D471/06 , C07D471/10
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 6具有权利要求1中给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
2.
公开(公告)号:US08129423B2
公开(公告)日:2012-03-06
申请号:US11871318
申请日:2007-10-12
申请人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
发明人: Jean Ackermann , Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander V. Mayweg , Werner Neidhart , Tadakatsu Takahashi
IPC分类号: A61K31/4152 , A61K31/4166 , C07D233/02
CPC分类号: C07D233/02 , A61K9/2054 , A61K9/4866 , C07D233/06 , C07D233/10 , C07D233/28 , C07D471/06 , C07D471/10
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 6具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US07482341B2
公开(公告)日:2009-01-27
申请号:US11238598
申请日:2005-09-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D401/02 , A61K31/44
CPC分类号: C07D213/76 , C07D401/12 , C07D413/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式的化合物及其药学上可接受的盐和酯,其中R 1至R 6具有权利要求1中给出的含义,可以以药物组合物的形式使用。
-
公开(公告)号:US20070049574A1
公开(公告)日:2007-03-01
申请号:US11511542
申请日:2006-08-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/55 , A61K31/4745 , A61K31/4439 , A61K31/426 , A61K31/416 , A61K31/4152 , C07D487/02 , C07D471/02 , C07D403/02
CPC分类号: C07D231/20 , C07D231/22 , C07D231/26 , C07D231/54 , C07D231/56 , C07D471/04 , C07D487/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 4具有权利要求1给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
公开(公告)号:US20070010519A1
公开(公告)日:2007-01-11
申请号:US11481330
申请日:2006-07-05
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/502 , C07D237/36 , C07D237/28
CPC分类号: C07D403/04 , C07D237/08 , C07D237/26 , C07D237/28 , C07D417/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 4具有权利要求1给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
公开(公告)号:US20060074237A1
公开(公告)日:2006-04-06
申请号:US11238598
申请日:2005-09-29
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D417/02 , C07D413/02 , C07D401/02
CPC分类号: C07D213/76 , C07D401/12 , C07D413/04
摘要: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 其中R 1至R 6具有权利要求1中给出的含义的式及其药学上可接受的盐和酯的化合物可以以药物组合物的形式使用。
-
7.
公开(公告)号:US07528159B2
公开(公告)日:2009-05-05
申请号:US11189598
申请日:2005-07-26
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/4418 , C07D213/75
CPC分类号: C07D213/76
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
摘要翻译: 式(I)化合物及其药学上可接受的盐和酯以药物组合物的形式使用。
-
8.
公开(公告)号:US08211913B2
公开(公告)日:2012-07-03
申请号:US12372244
申请日:2009-02-17
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D213/02 , A61K31/44
CPC分类号: C07D213/76
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
摘要翻译: 式(I)化合物及其药学上可接受的盐和酯以药物组合物的形式使用。
-
9.NEW 5-ARYL PYRIDINES AS 11-BETA INHIBITORS FOR THE TREATMENT OF DIABETES 失效
标题翻译: 新的5-ARYL PYRIDINES作为治疗糖尿病的11-β抑制剂公开(公告)号:US20090149503A1
公开(公告)日:2009-06-11
申请号:US12372244
申请日:2009-02-17
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: A61K31/444 , C07D213/02 , A61P3/10
CPC分类号: C07D213/76
摘要: Compounds of formula (I): as well as pharmaceutically acceptable salts and esters thereof used in the form of pharmaceutical compositions.
摘要翻译: 式(I)化合物及其药学上可接受的盐和酯以药物组合物的形式使用。
-
公开(公告)号:US07507733B2
公开(公告)日:2009-03-24
申请号:US11168031
申请日:2005-06-27
申请人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
发明人: Kurt Amrein , Daniel Hunziker , Bernd Kuhn , Alexander Mayweg , Werner Neidhart
IPC分类号: C07D239/69 , A61K31/505
CPC分类号: C07D401/12 , C07D239/69 , C07D409/14 , C07D413/12
摘要: Compounds of the formula (I): as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
摘要翻译: 式(I)的化合物及其药学上可接受的盐和酯,其中R 1至R 5具有权利要求1中给出的含义可以以药物组合物的形式使用。
-
-
-
-
-
-
-
-
-